Literature DB >> 2025956

Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis.

H Löhr1, M Manns, A Kyriatsoulis, A W Lohse, C Trautwein, K H Meyer zum Büschenfelde, B Fleischer.   

Abstract

Autoantibodies against microsomal antigen of liver and kidney (LKM-1) are diagnostic markers for a subgroup of autoimmune chronic active hepatitis (AI-CAH). Cytochrome P450dbl, now classified as cytochrome P450 IID6, is the major antigen of LKM-1 antibodies. Immunohistological studies suggest that hepatic injury in AI-CAH is mediated by liver-infiltrating T cells. In the present study the specificity and function of liver-infiltrating T cells was analysed at the clonal level. Phenotypical characterization of 189 T cell clones isolated from four liver biopsies of LKM-1 antibody-positive patients showed an enrichment of CD4+ CD8- T cell clones proliferated specifically in the presence of recombinant human LKM-1 antigen (rLKM). This reaction was restricted to autologous antigen-presenting cells and to HLA class II molecules. In order to see whether rLKM was also recognized by peripheral blood T lymphocytes (PBL) we tested the proliferative response of PBL from several individuals. PBL from three of the four patients with LKM-1 antibody-positive AI-CAH proliferated to rLKM, whereas no response was seen with PBL from patients with LKM-1 antibody-negative chronic liver diseases and from healthy blood donors. These data demonstrate that the LKM-1 antigen is recognized by liver-infiltrating T cells in LKM-1 antibody-positive AI-CAH. For further functional characterization, liver-derived T cell clones were tested for their cytotoxic activity. In the presence of phytohaemagglutinin 24 out of 26 CD4- CD8+ but also 20 out of 63 CD4+ CD8- T cell clones lysed autologous as well as allogenic EBV-transformed B cell lines or K562 cells. Five CD4- CD8+ T cell clones lysed autologous but not allogenic B cell lines spontaneously in a HLA class I-restricted manner. Although the antigen specificity of these clones is still unknown the data show the presence of autoreactive T cells at the site of inflammation that could contribute in the pathogenesis of AI-CAH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025956      PMCID: PMC1535412          DOI: 10.1111/j.1365-2249.1991.tb08164.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis.

Authors:  J C Homberg; N Abuaf; O Bernard; S Islam; F Alvarez; S H Khalil; R Poupon; F Darnis; V G Lévy; P Grippon
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

3.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

Review 4.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

5.  Norepinephrine-induced cholestasis in the isolated perfused rat liver is secondary to its hemodynamic effects.

Authors:  R Lenzen; A Funk; V Kolb-Bachofen; G Strohmeyer
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

6.  Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis.

Authors:  B Fleischer; H W Kreth
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

7.  A beta-galactosidase linked immunoassay for the analysis of antigens on individual cells.

Authors:  B Holzmann; J P Johnson
Journal:  J Immunol Methods       Date:  1983-06-10       Impact factor: 2.303

8.  Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.

Authors:  G R Pape; E P Rieber; J Eisenburg; R Hoffmann; C M Balch; G Paumgartner; G Riethmüller
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

9.  Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases.

Authors:  M Manns; K H Meyer zum Büschenfelde; J Slusarczyk; H P Dienes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

10.  Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; L Alviggi; G Mieli-Vergani; B Portmann; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

View more
  26 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Cytochrome P450 enzymes as human autoantigens.

Authors:  M P Manns
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

Review 4.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 5.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

6.  Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.

Authors:  E Cunha-Neto; V Coelho; L Guilherme; A Fiorelli; N Stolf; J Kalil
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 7.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

Review 8.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

9.  Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis.

Authors:  J F Schlaak; H Löhr; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 10.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.